Nugenics Research Private Limited
About Nugenics Research Private Limited
Data last updated:
Nugenics Research Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 25 April 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2018PTC308550. Its GSTIN is 27AAGCN0432N1ZC (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1.17 Lakh. It is led by directors Jay Kanwalkishore Arora and Harshvardhan Akshay Sanghavi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 303 Kumar Plaza 3rd Floor Kalina Kurla Road Santacruz East Near Kalina Masjid, Mumbai, Maharashtra, India – 400029.
As per the financials filed for FY 2024, the company reported a revenue of ₹18.92 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹2.17 Lakh (net margin -11.5%) and EBITDA of -₹1.54 Lakh (EBITDA margin -8.2%). Revenue has declined at a compounded annual rate (CAGR) of 13% over three years.
Company details
Contact details
Nugenics Research Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered Address303 Kumar Plaza 3rd Floor Kalina Kurla Road Santacruz East Near Kalina Masjid, Mumbai, Maharashtra, India – 400029
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Nugenics Research Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Nugenics Research is professional, scientific and technical activities. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, scientific and technical activities | 72 | Scientific research and development |
To see the full business activity and turnover split of Nugenics Research Private Limited, buy the company report.
Financials of Nugenics Research Private Limited
FY 2025 filings availableNugenics Research Private Limited reported revenue of ₹18.92 Lakh (up 830% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 830% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 13%. EBITDA rose 87% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.54 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2.17 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -8.2% | ||||
| Net Profit Margin | -11.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Nugenics Research Private Limited, buy the company report.
Board of directors of Nugenics Research Private Limited
Nugenics Research has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jay Kanwalkishore Arora | Director | 02 Mar 2020 | 6 Years 8 Months | Current |
| Harshvardhan Akshay Sanghavi | Director | 25 Apr 2018 | 8 Years 6 Months | Current |
Auditor
Nugenics Research Private Limited is audited by R R GANDHI AND CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R R GANDHI AND CO | FY 2021 | 145617W |
Shareholding
The shareholding of Nugenics Research Private Limited is on record for FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Nugenics Research Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Nugenics Research Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nugenics Research Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Nugenics Research has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAGCN0432N1ZC | Maharashtra | Active | 25 Nov 2021 |
To see the full GST registrations and return filing status of Nugenics Research Private Limited, buy the company report.
Recent activity
Nugenics Research Private Limited has 3 board changes on record since 2018: 2 appointments and 1 cessation. The latest: Sureshkumar Pukhraj Jain ceased to be Director on 11 Jan 2023.
Frequently asked questions
Nugenics Research is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 25 April 2018 (8+ years old) and is registered under CIN U74999MH2018PTC308550.
Nugenics Research has 2 current directors:
- Jay Kanwalkishore Arora - Director
- Harshvardhan Akshay Sanghavi - Director
The latest financial statements of Nugenics Research on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Nugenics Research is 27AAGCN0432N1ZC, registered in Maharashtra.
The CIN (Corporate Identification Number) of Nugenics Research is U74999MH2018PTC308550. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nugenics Research was incorporated on 25 April 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
Sureshkumar Pukhraj Jain ceased to be Director on 11 Jan 2023. Jay Kanwalkishore Arora was appointed as Director on 02 Mar 2020. Harshvardhan Akshay Sanghavi was appointed as Director on 25 Apr 2018.
The registered office of Nugenics Research is at 303 Kumar Plaza 3rd Floor Kalina Kurla Road Santacruz East Near Kalina Masjid, Mumbai, Maharashtra, India – 400029.
Nugenics Research operates in the pharma industry, in the pharma contract r and d segment.
Nugenics Research can be reached at its registered office: 303 Kumar Plaza 3rd Floor Kalina Kurla Road Santacruz East Near Kalina Masjid, Mumbai, Maharashtra, India – 400029.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
